Pulmonary Thromboembolism in a Patient With Rheumatic Mitral Valve Stenosis: A Fortuitous Association?

2011 ◽  
Vol 92 (6) ◽  
pp. 2263-2266 ◽  
Author(s):  
Qiang Zhao ◽  
Xiaofeng Ye ◽  
Jun Liu ◽  
Haitao Chen ◽  
Dan Zhu ◽  
...  
1998 ◽  
Vol 23 (2) ◽  
pp. 204-209 ◽  
Author(s):  
Beatrice Afrangui ◽  
A. M. Malinow

Background and ObjectivesWe present a report of a parturient with severe mitral valve stenosis diagnosed during a previous pregnancy who developed severe preeclampsia.MethodsLabor and subsequent abdominal delivery were managed with epidural analgesia and anesthesia. The clinical management was guided by invasive hemodynamic monitoring, including a flow-directed pulmonary artery catheter.ConclusionsPeripartum maternal and neonatal outcomes were satisfactory. Postpartum complications included pulmonary edema as well as peripartum heart failure and pulmonary thromboembolism 4 weeks postpartum.


1999 ◽  
Vol 1 ◽  
pp. S87-S87
Author(s):  
R ROSENHEK ◽  
T BINDER ◽  
G PORENTA ◽  
G MAURER ◽  
H BAUMGARTNER

2007 ◽  
Vol 10 (4) ◽  
pp. E325-E328 ◽  
Author(s):  
Ali Gürbüz ◽  
Ufuk Yetkin ◽  
Ömer Tetik ◽  
Mert Kestelli ◽  
Murat Yesil

Author(s):  
Ashvarya Mangla ◽  
Ameer Musa ◽  
Clifford J Kavinsky ◽  
Hussam S Suradi

Abstract Background Transcatheter mitral valve-in-valve implantation (MVIV) has emerged as a viable treatment option in patients at high risk for surgery. Occasionally, despite appropriate puncture location and adequate dilation, difficulty is encountered in advancing the transcatheter heart valve across interatrial septum. Case summary We describe a case of a 79-year-old woman with severe chronic obstructive pulmonary disease (COPD), prior surgical bioprosthetic aortic and mitral valve replacement implanted in 2007, atrial fibrillation, and Group II pulmonary hypertension who presented with progressively worsening heart failure symptoms secondary to severe bioprosthetic mitral valve stenosis and moderate-severe mitral regurgitation. Her symptoms had worsened over several months, with multiple admissions at other institutions with treatment for both COPD exacerbation and heart failure. Transoesophageal echocardiogram demonstrated preserved ejection fraction, normal functioning aortic valve, and dysfunctional mitral prosthesis with severe stenosis (mean gradient 13 mmHg) and moderate-severe regurgitation. After a multi-disciplinary heart team discussion, the patient underwent a transcatheter MVIV implantation. During the case, inability in advancing the transcatheter heart valve (THV) across interatrial septum despite adequate septal balloon pre-dilation was successfully managed with the support of a stiff ‘buddy wire’ anchored in the left upper pulmonary vein using the same septal puncture. The patient tolerated the procedure well and was discharged home. Discussion Operators should be aware of potential strategies to advance the THV when difficulty is encountered in crossing the atrial septum despite adequate septal preparation. One such strategy is the use of stiff ‘buddy wire’ for support which avoids the need for more aggressive septal dilatation.


Author(s):  
Georg Lutter ◽  
Mohamed Salem ◽  
Derk Frank ◽  
Thomas Puehler

Abstract Background Transcatheter aortic valve replacement (TAVR) in combination with a valve-in-valve (V-i-V) transcatheter mitral valve replacement (TMVR) is a rare procedure in comparison to surgical therapy especially in young patients. We report on a young patient at high surgical risk, receiving a double valve implantation with two S3 transcatheter heart valves. Case summary A 59-year-old female patient with two previous mitral valve replacements due to endocarditis and re-endocarditis experienced a new onset of severe mitral valve stenosis in combination with progredient aortic stenosis. She was admitted to the hospital with severe dyspnoea and intermittent non-invasive ventilation [New York Heart Association (NYHA) III–IV]. An interventional transapical transcatheter double valve implantation was planned and carried out due to cardiac decompensation and high comorbidity preoperatively (STS score of 6.92). At 6-month follow-up, the patient presented herself in an improved condition with reduced symptoms (NYHA I–II), a good functional status of both valves and an advanced right and left ventricular function in the echocardiogram. Discussion Even in younger patients at high risk, a combined native TAVR and V-i-V TMVR procedure can be performed. In this case, a transcatheter SAPIEN 3 valve was transapically implanted with good clinical mid-term outcome at 6 months.


1992 ◽  
Vol 70 (4) ◽  
pp. 553-554 ◽  
Author(s):  
Eugenio Martuscelli ◽  
Francesco Romeo ◽  
Giuseppe M.C. Rosano ◽  
Arnaldo G. Macchiarelli ◽  
Riccardo Sinatra ◽  
...  

2016 ◽  
Vol 31 (9) ◽  
pp. 596-598 ◽  
Author(s):  
Yasuyuki Yamada ◽  
Ikuko Shibasaki ◽  
Toshiyuki Kuwata ◽  
Hirotsugu Fukuda

Author(s):  
Charles V. Pollack ◽  
Jaime Friel Blanck

Sign in / Sign up

Export Citation Format

Share Document